NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9480	Companies
185527	Keywords
117915	Articles
99372	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 10/31/2024 at 08:30, 1 year 1 month ago

NANOBIOTIX to Participate in Multiple Investor Conferences in November
Nanobiotix to participate in multiple investor conferences in November, including Guggenheim, Stifel, and Jefferies events to discuss innovative healthcare approaches

Investor Conferences Healthcare Innovation NANOBIOTIX Nanoparticle-based Approaches Late-stage Biotechnology
BRIEF

published on 10/11/2024 at 22:20, 1 year 1 month ago

Voting Rights and Share Capital Update by Nanobiotix

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 10/11/2024 at 22:20, 1 year 1 month ago

Mise à jour des droits de vote et du capital social par Nanobiotix

Euronext Paris Capital Social Nasdaq Droit De Vote NANOBIOTIX
PRESS RELEASE

published on 10/11/2024 at 22:15, 1 year 1 month ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses voting rights and shares capital information. Find out more about the company's innovative therapeutic approaches

Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
PRESS RELEASE

published on 10/11/2024 at 22:15, 1 year 1 month ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix publie mensuellement le nombre total d'actions et de droits de vote. La société de biotechnologie développe des traitements innovants. Pour plus d'informations, visitez www.nanobiotix.com

Droits De Vote Biotechnologie Actions Traitements NANOBIOTIX
PRESS RELEASE

published on 09/18/2024 at 22:42, 1 year 2 months ago

Rapport Financier Semestriel 2024
BRIEF

published on 09/18/2024 at 22:20, 1 year 2 months ago

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results

Revenue Increase Clinical Milestones Nanobiotix Financials NBTXR3 Progress Cash And Runway
BRIEF

published on 09/18/2024 at 22:20, 1 year 2 months ago

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers du premier semestre 2024

Augmentation Des Revenus Résultats Financiers De Nanobiotix Progression De NBTXR3 Étapes Cliniques Marquantes De L'argent Et De La Piste
PRESS RELEASE

published on 09/18/2024 at 22:15, 1 year 2 months ago

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
Nanobiotix updates on operational progress and reports Half Year 2024 financial results, showcasing clinical milestones and licensing agreements with Janssen. Cash reserves extended until Q4 2025

Financial Results Clinical Milestones NANOBIOTIX Half Year 2024 Janssen Agreement
PRESS RELEASE

published on 09/18/2024 at 22:15, 1 year 2 months ago

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024
Nanobiotix publie ses résultats financiers et présente les avancées de NBTXR3, une approche innovante en oncologie basée sur les nanoparticules. Nouvelles collaborations et perspectives de développement clinique

Résultats Financiers Oncologie NANOBIOTIX NBTXR3 Nanoparticules

Accesswire

Published on 12/05/2025 at 18:45, 17 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 42 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 2 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 47 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 2 hours 2 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 4 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 35 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 46 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 10 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 16 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 44 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 44 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 51 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 51 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 3 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE